Myopathy associated with epsilon-aminocaproic acid (EACA) therapy
- 1 October 1978
- journal article
- research article
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery
- Vol. 49 (4) , 597-601
- https://doi.org/10.3171/jns.1978.49.4.0597
Abstract
The association of myopathy with epsilon-aminocaproic acid (EACA) treatment after subarachnoid hemorrhage in 2 cases is reported. Clinical and laboratory findings and possible mechanisms are discussed in light of the known pharmacology of the drug. Recovery ensues if EACA treatment is terminated as soon as myopathy appears.This publication has 7 references indexed in Scilit:
- Normal cerebral arteriography in patients with spontaneous subarachnoid hemorrhageNeurology, 1977
- Intracranial Aneurysms and Subarachnoid Hemorrhage. A Cooperative Study. Antifibrinolytic Therapy in Recent Onset Subarachnoid HemorrhageStroke, 1975
- Arteriopathic complications during treatment of subarachnoid hemorrhage with epsilon-aminocaproic acidJournal of Neurosurgery, 1974
- MyoglobinuriaMedical Clinics of North America, 1972
- Myopathy from E-aminocaproic acid: a second casePublished by Oxford University Press (OUP) ,1972
- The Complications of Therapy with Epsilon-Aminocaproic AcidMedical Clinics of North America, 1966
- Thrombotic State after a Hemorrhagic Diathesis, a Possible Complication of Therapy with Epsilon-Aminocaproic AcidBlood, 1962